1. Home
  2. PTCT vs PACS Comparison

PTCT vs PACS Comparison

Compare PTCT & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$78.64

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo PACS Group Inc.

PACS

PACS Group Inc.

HOLD

Current Price

$36.04

Market Cap

5.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
PACS
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.7B
IPO Year
2006
2024

Fundamental Metrics

Financial Performance
Metric
PTCT
PACS
Price
$78.64
$36.04
Analyst Decision
Buy
Strong Buy
Analyst Count
17
4
Target Price
$80.65
$45.50
AVG Volume (30 Days)
1.5M
728.1K
Earning Date
05-07-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
221.05
EPS
N/A
0.50
Revenue
$264,734,000.00
$5,288,932,000.00
Revenue This Year
N/A
$10.19
Revenue Next Year
$17.70
$8.58
P/E Ratio
N/A
$70.66
Revenue Growth
36.19
29.32
52 Week Low
$43.18
$7.50
52 Week High
$87.50
$43.08

Technical Indicators

Market Signals
Indicator
PTCT
PACS
Relative Strength Index (RSI) 63.26 49.64
Support Level $73.41 $32.91
Resistance Level $79.67 $36.45
Average True Range (ATR) 3.08 1.67
MACD 0.67 -0.15
Stochastic Oscillator 89.41 47.39

Price Performance

Historical Comparison
PTCT
PACS

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About PACS PACS Group Inc.

PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.

Share on Social Networks: